Vir Biotechnology Inc. VIR announced a major collaboration with Gilead Sciences Inc. GILD to create three novel T-cell ...

Veteran oncology regulator brings more than 25 years of FDA experience as Siren advances SRN-101 into clinical developmentSAN FRANCISCO, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, a ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Sana Biotechnology trades at a steep discount despite promising T1D assets UP421 and SC451. Check out why SANA stock is a buy ...

Vir Biotechnology ( ($VIR) ) has provided an update. On October 9, 2026, Vir Biotechnology entered a collaboration and license agreement with Gilead Sciences to ...

The Defense Innovation Networking Group (D!NG) today announced that the submission window is officially open for the ...

Vir Biotechnology is now a two-engine company, with major pharma partnerships and a fully enrolled hepatitis delta phase 3 program. See why VIR stock is a buy.

Vir Biotechnology, entered a collaboration and license agreement with Gilead to discover and engineer three novel PRO-XTEN dual-masked T-cell engager development candidates target ...

Vir Biotechnology has appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer, effective October 5, 2026 ...

The Minister of Education, Dr Tunji Alausa, has described biotechnology as a critical tool for addressing food insecurity, malnutrition and emerging health challenges, urging researchers, government ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...